What are the recommended analgesic doses of ketamine for adults and pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ketamine Analgesic Dosing

For pure analgesia without dissociation, administer ketamine at 0.2-0.3 mg/kg IV, which provides effective pain relief while avoiding the dissociative state that occurs at higher doses.

Dose-Response Relationship

Ketamine exhibits distinct clinical effects at different dose ranges, which is critical to understand for analgesic use 1:

  • Pure analgesia: 0.2-0.3 mg/kg IV
  • Hallucinatory distortion: 0.6-0.7 mg/kg IV
  • Dissociative threshold: 1.5-2 mg/kg IV in children; 1-1.5 mg/kg IV in adults

Unlike other sedatives, ketamine does not follow a traditional dose-response continuum—once the dissociative threshold is reached, additional doses do not deepen sedation 1.

FDA-Approved Dosing for Anesthesia

The FDA label provides these ranges, though these are for anesthetic (not purely analgesic) purposes 2:

Intravenous Route

  • Initial dose range: 1-4.5 mg/kg IV
  • Average anesthetic dose: 2 mg/kg IV (produces 5-10 minutes of surgical anesthesia)
  • Administration: Slowly over 60 seconds to avoid respiratory depression
  • Maintenance infusion: 0.1-0.5 mg/minute for general anesthesia

Intramuscular Route

  • Initial dose range: 6.5-13 mg/kg IM
  • Typical anesthetic dose: 9-13 mg/kg IM (produces anesthesia in 3-4 minutes, lasting 12-25 minutes)

Pediatric Analgesic Dosing

For procedural sedation in children, 1-1.5 mg/kg IV is optimal 3, 4:

  • Doses of 1.5 mg/kg IV require fewer total doses and lower cumulative mg/kg compared to 1 mg/kg IV 4
  • At 1-1.5 mg/kg IV, nearly 90% effectiveness was achieved 3
  • Patients <2 years have higher rates of unsatisfactory analgesia (28.7%) and may require dose adjustment 3
  • Procedures >20 minutes often require repeat dosing 3

Intranasal Ketamine (Pediatrics)

  • Effective dose range: 3-5 mg/kg intranasal provides optimal patient comfort 5
  • Bioavailability is only 50% in pediatric patients 6
  • Doses between 3.6-4 mg/kg intranasal had higher failure rates (66.7%) 3
  • Treatment failure rate: 7.7% overall 5

Alternative Routes

Nebulized Ketamine (Adults)

Recent evidence supports nebulized ketamine for acute pain 7:

  • Effective doses: 0.7-1.5 mg/kg nebulized
  • Pain reduction: 42.5% at 15 minutes, 70.4% at 120 minutes
  • Higher doses (1.5 mg/kg) showed no significant advantage over lower doses (0.7 mg/kg)
  • Non-inferior to IV morphine with fewer side effects

Oral Ketamine (Chronic Pain)

For chronic pain management 8:

  • Recommended regimen: 0.5 mg/kg orally three times daily
  • Duration: 7-90 days for chronic pain
  • Bioavailability: Only 17-18% due to first-pass metabolism 6
  • Mean pain reduction from 7.72/10 to 3.2/10 over 30-90 days

Critical Safety Considerations

The 100 mg/mL concentration must be diluted before IV administration 2. Dilute with equal volume of sterile water, normal saline, or D5W and use immediately.

Administration Precautions

  • Administer IV doses slowly over 60 seconds—rapid administration causes respiratory depression and enhanced vasopressor response 2
  • Emergency airway equipment must be immediately available 2
  • Monitor vital signs and cardiac function continuously 2
  • Consider antisialagogue prior to administration due to increased secretions 2

Common Pitfalls

  • Arthrocentesis procedures have the highest failure rate (39.3%) with standard IV dosing 3
  • Doses in the 1.6-2 mg/kg range (both initial and total) had significantly higher unsatisfactory results (11.8-17.6%) 3
  • Intranasal administration has higher failure rates (36.4%) compared to IV 3

Contraindications

Ketamine is contraindicated in 2:

  • Patients where blood pressure elevation would be hazardous
  • Known hypersensitivity to ketamine
  • Patients who have not followed NPO guidelines (relative contraindication)

Adverse Effects

Short-term: dizziness, mild dysphoria, nausea (1.5%), drowsiness (1%) 5, 9
Long-term concerns: hepatobiliary injury, cystitis with chronic use 9, 10

For pure analgesia in acute settings, start with 0.2-0.3 mg/kg IV; for procedural sedation requiring dissociation, use 1-1.5 mg/kg IV in adults or 1.5-2 mg/kg IV in children, administered slowly over 60 seconds with continuous monitoring.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.